[go: up one dir, main page]

WO2012072409A2 - Procédé de traitement des odeurs corporelles combinant un produit désodorisant topique et un parfum administré par voie orale; nécessaire désodorisant - Google Patents

Procédé de traitement des odeurs corporelles combinant un produit désodorisant topique et un parfum administré par voie orale; nécessaire désodorisant Download PDF

Info

Publication number
WO2012072409A2
WO2012072409A2 PCT/EP2011/070062 EP2011070062W WO2012072409A2 WO 2012072409 A2 WO2012072409 A2 WO 2012072409A2 EP 2011070062 W EP2011070062 W EP 2011070062W WO 2012072409 A2 WO2012072409 A2 WO 2012072409A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
fragrancing
perfume
process according
edible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/070062
Other languages
English (en)
Other versions
WO2012072409A3 (fr
Inventor
Isabelle Bara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2012072409A2 publication Critical patent/WO2012072409A2/fr
Publication of WO2012072409A3 publication Critical patent/WO2012072409A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0229—Sticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Definitions

  • the invention relates to a cosmetic process for treating body odour, which comprises the following steps:
  • composition (B) comprising, in a medium that is suitable for oral application, at least one edible fragrancing substance capable of producing an odour from within the body out to the human keratin materials; the order of the steps being irrelevant and the application of compositions (A) and (B) possibly being simultaneous or sequential within a time interval ranging from 30 seconds to 12 hours.
  • the invention also relates to a deodorizing kit or device comprising at least two compartments, characterized in that it comprises:
  • composition (B) as defined previously.
  • a perfume is a combination of different odoriferous substances that evaporate at different periods. It is possible to classify a perfume according to its olfactory family, and to describe it as a function of the notes that appear during its use. These olfactory notes are divided into head notes (which are those associated with the first olfactory impression and are the most volatile), heart notes (which are those that constitute the heart of the perfume and remain for several hours), and finally base notes (which are those that persist for a long time after the perfume has vaporized, and which may remain for months on clothing). Certain perfumes may, however, have a different olfactory construction, i.e. they may bear one or two of these notes.
  • perfume it is common practice to incorporate perfume into a certain number of products or compositions, in particular cosmetic or dermatological products or compositions, applied directly via the topical route to keratin materials, in particular the skin.
  • products are generally in the form of eau fraiche, perfume de toilette or eau de toilette, eau de perfume, elixir de perfume or tinct de perfume, aftershave lotion or eau de soin.
  • perfume diffuses mainly from the area of application. Products for improving or modifying the odour of the body after ingestion of particular edible fragrancing substances have appeared on the market in recent years.
  • chlorophyll derivatives such as chlorophylline.
  • Examples include the product Chlorophyll 1001 from Biomed in Switzerland, and Deodorin from Eryo in France and the USA. These products are sold for limiting unpleasant body odour. Such products are described especially in documents JP10245343 (Taisho Pharmaceutical Co), WO 2004/10574 (Mitchell Kurk Lawrence, NY) and JP2002224203.
  • Products claiming "perfuming" of the body by ingestion of products containing particular molecules have recently been noted on the essentially asiatic market. These products are sold in the form of sweets or the like (drinks, chewing gum, gel capsules, etc.).
  • Ingestible cosmetic products preferably sweets or chewing gums, comprising at least one polar compound and/or one terpene for perfuming the body after ingestion, with edible perfuming molecules such as geraniol, linolool and citronellol, are also known in patent application WO 2006/129 876 from Kanebo Foods Ltd. Since 2006, the company Kanebo has been selling chewing gums under the trade name Fuwarinka for the purpose of perfuming the skin from within (based on geraniol, rose essence and lemon). The company Wasaka sells gel capsules under the brand name Sofia, based on rose essence.
  • Patent application WO 2004/10574 from Mitchell Kurk Lawrence, NY, mentions ingestible essential oils in a composition for the purpose also of deodorizing "unpleasant skin odours".
  • Patent application JP 2002224203 recommends the plant extract of a legume ⁇ Cesalpinia paraensis) as an oral deodorant. The extract is not odoriferous: it is used as an active agent for combating unpleasant odour.
  • the efficacy is perceptible only at the place of application, and it is common practice to apply a deodorant to the places where the perspiration is strongest (armpits, feet, etc.). Often, larger parts of the body may give off unpleasant body odour. It is neither easy nor recommended to apply a deodorant or an antiperspirant to the entire surface of the body. Moreover, the efficacy over time of a deodorant is limited. When a person perspires excessively or goes swimming (in the sea), the deodorant is no longer effective.
  • composition (B) comprising, in a medium that is suitable for oral application, at least one edible fragrancing substance capable of producing an odour from within the body out to the human keratin materials; the order of the steps being irrelevant and the application of compositions (A) and (B) possibly being simultaneous or sequential within a time interval ranging from 30 seconds to 12 hours.
  • the invention relates to a cosmetic process for treating body odour, which comprises the following steps:
  • composition (B) comprising, in a medium that is suitable for oral application, at least one edible fragrancing substance capable of producing an odour from within the body out to the human keratin materials; the order of the steps being irrelevant and the application of compositions (A) and (B) possibly being simultaneous or sequential within a time interval ranging from 30 seconds to 12 hours.
  • the invention also relates to a deodorizing kit or device comprising at least two compartments, characterized in that it comprises:
  • composition (B) as defined previously.
  • human keratin materials means the skin (face, body, lips), the scalp, the hair, the eyelashes, the eyebrows, the nails or mucous membranes.
  • deodorant active agent refers to any substance that is capable of masking, absorbing, improving and/or reducing the unpleasant odour resulting from the decomposition of human sweat by bacteria.
  • fragmentrancing substance means any perfume or aroma capable of giving off a pleasant odour.
  • ible substance means any non-toxic substance that is suitable for oral application, in the oral cavity and on the lips.
  • cosmetically acceptable medium means a non-toxic medium that may be applied directly to the skin (face, body or lips), the scalp, the hair, the eyelashes, the eyebrows, the scalp, the nails and mucous membranes.
  • composition (A) and of composition (B) The term “sequential” means the separate application over time of composition (A) and of composition (B). The user may thus successively apply composition (A) and composition (B), the order being irrelevant within a time interval ranging from 30 seconds to 12 hours.
  • the deodorizing composition (A) according to the invention contains one or more deodorant active agents, for instance:
  • bacteriostatic agents or bactericidal agents such as 2,4,4'-trichloro-2'- hydroxydiphenyl ether (triclosan), 2,4-dichloro-2'-hydroxydiphenyl ether, 3',4',5'- trichlorosalicylanilide, 1 -(3',4'-dichlorophenyl)-3-(4'-chlorophenyl)urea (triclocarban) or 3,7, 1 1 -trimethyldodeca-2, 5,10-trienol (Farnesol); quaternary ammonium salts, for instance cetyltrimethylammonium salts, cetylpyridinium salts; chlorhexidine and salts; diglyceryl monocaprate, diglyceryl monolaurate or glyceryl monolaurate; polyhexamethylene biguanide salts;
  • zinc salts such as zinc salicylate, zinc phenolsulfonate, zinc pyrrolidonecarboxylate (more commonly known as zinc pidolate), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate, zinc ricinoleate, zinc glycinate, zinc carbonate, zinc citrate, zinc chloride, zinc laurate, zinc oleate, zinc orthophosphate, zinc stearate, zinc tartrate, zinc lactate or zinc acetate, or mixtures thereof;
  • - odour absorbers such as zeolites, cyclodextrins, metal oxide silicates such as those described in patent application US 2005/063 928; metal oxide particles modified with a transition metal, as described in patent applications US 2005/084 464 and US 2005/084 474, aluminosilicates such as those described in patent application EP 1 658 863, chitosan-based particles such as those described in patent US 6 916 465;
  • arylsulfatase 5-lipoxygenase, aminocylase or ⁇ - glucuronidase inhibitors
  • the deodorant active agents may be present in composition (A) according to the invention in a proportion of from 0.01 % to 10% by weight and preferably in a proportion of from 0.1 % to 5% by weight relative to the total weight of the composition.
  • deodorant active agents mention may also be made of antiperspirant active agents.
  • antiperspirant active agent means any substance which, by itself, has the effect of reducing or limiting the flow of sweat.
  • the antiperspirant active agents are preferably chosen from aluminium and/or zirconium salts; complexes of zirconium hydroxychloride and of aluminium hydroxychloride with an amino acid, such as those described in patent US-3 792 068, commonly known as "ZAG complexes". Such complexes are generally known under the name "ZAG” (when the amino acid is glycine). ZAG complexes ordinarily have an Al/Zr quotient ranging from about 1 .67 to 12.5 and a metal/CI quotient ranging from about 0.73 to 1 .93.
  • aluminium zirconium octachlorohydrex GLY aluminium zirconium pentachlorohydrex GLY, aluminium zirconium tetrachlorohydrate GLY and aluminium zirconium trichlorohydrate GLY.
  • aluminium salts that may be mentioned are aluminium chlorohydrate, aluminium chlorohydrex, aluminium chlorohydrex PEG, aluminium chlorohydrex PG, aluminium dichlorohydrate, aluminium dichlorohydrex PEG, aluminium dichlorohydrex PG, aluminium sesquichlorohydrate, aluminium sesquichlorohydrex PEG, aluminium sesquichlorohydrex PG, alum salts, aluminium sulfate, aluminium zirconium octachlorohydrate, aluminium zirconium pentachlorohydrate, aluminium zirconium tetrachlorohydrate, aluminium zirconium trichlorohydrate and more particularly the aluminium hydroxychloride sold by the company Reheis under the name Reach 301 or by the company Guilini Chemie under the name Aloxicoll PF 40. Aluminium zirconium salts are, for example, the salt sold by the company Reheis under the name Reach AZP-908-SUF.
  • An aluminium chlorohydrate
  • the antiperspirant active agents may be present in the composition according to the invention in a proportion of from 0.001 % to 30% by weight and preferably in a proportion of from 0.5% to 25% by weight relative to the total weight of the composition.
  • Composition (A) may be in any galenical form conventionally used for topical application and especially in the form of aqueous gels, or aqueous or aqueous-alcoholic solutions.
  • a fatty or oily phase By adding a fatty or oily phase, it may also be in the form of dispersions of lotion type, emulsions of liquid or semi- liquid consistency of the milk type, obtained by dispersing a fatty phase in an aqueous phase (O/W) or conversely (W/O), or suspensions or emulsions of soft, semi-solid or solid consistency of the cream or gel type, or alternatively multiple emulsions (W/O/W or 0/W/O), microemulsions, vesicular dispersions of ionic and/or nonionic type, or wax/aqueous phase dispersions.
  • the deodorant compositions are prepared according to the usual methods.
  • the deodorant compositions are conditioned in an aerosol device or in a pump-action bottle; in a device equipped with a perforated wall such as a grille; in the form of cream in a tube; in the form of a ball (roll-on); in the form of wands (sticks); in the form of powder; in the form of wipes.
  • they contain the ingredients generally used in products of this type, which are well known to those skilled in the art.
  • compositions according to the invention intended for cosmetic use may comprise at least one aqueous phase. They are especially formulated as aqueous lotions or as water-in-oil or oil-in-water emulsions or as multiple emulsions (oil-in- water-in-oil or water-in-oil-in-water triple emulsion (such emulsions are known and described, for example, by C. FOX in "Cosmetics and Toiletries” - November 1986 - Vol. 101 - pages 101 -1 12)).
  • the aqueous phase of the said compositions contains water and generally other water-soluble or water-miscible solvents.
  • the water-soluble or water-miscible solvents comprise monoalcohols with a short chain, for example of Ci-C 4 , such as ethanol or isopropanol; diols or polyols, for instance ethylene glycol, 1 ,2-propylene glycol, 1 ,3-butylene glycol, hexylene glycol, diethylene glycol, dipropylene glycol, 2-ethoxyethanol, diethylene glycol monomethyl ether, triethylene glycol monomethyl ether and sorbitol.
  • Propylene glycol and glycerol will be used more particularly.
  • the compositions of the invention may be anhydrous.
  • anhydrous means a composition whose content of free or added water is less than 3% and preferably whose content of added water is less than 1 % by weight relative to the total weight of the composition.
  • compositions according to the invention may contain at least one water- immiscible organic liquid phase.
  • This phase generally comprises one or more hydrophobic compounds that make the said phase water immiscible.
  • the said phase is liquid (in the absence of structuring agent) at room temperature (20- 25°C).
  • the water-immiscible organic liquid phase in accordance with the invention is generally formed from an oil or a mixture of oils and comprises at least 80% of compounds with a vapour pressure not exceeding 4 kPa (30 mmHg) at 25°C.
  • the water-immiscible organic liquid phase preferably contains one or more volatile or non-volatile silicone or hydrocarbon-based emollient oils. These emollient oils are especially described in patents US 4 822 596 and US 4 904 463.
  • Volatile silicones are defined, in a known manner, as compounds that are volatile at room temperature. Among these compounds, cyclic and linear volatile silicones of the dimethylsiloxane type whose chains comprise from 3 to 9 silicone residues may be mentioned. Cyclomethicones D 4 , D 5 or D 6 are preferably chosen. Non-volatile silicones are defined, in a known manner, as compounds with a low vapour pressure at room temperature.
  • polyalkylsiloxanes in particular linear polyalkylsiloxanes, for instance the linear polydimethylsiloxanes, or dimethicones, sold by the company Dow Corning under the name Dow Corning 245 Fluid
  • polyalkylarylsiloxanes for instance the polymethylphenylsiloxanes sold by the company Dow Corning under the name Dow Corning 556 Fluid
  • copolymers of polyether and siloxane for instance Dimethicone Copolyols.
  • non-volatile emollient oils examples include: hydrocarbon-based derivatives, mineral oils, fatty alcohols, esters of C3-C18 alcohols with C3-C18 acids, esters of benzoic acid with C12-C18 alcohols and mixtures thereof, C2-C6 polyols preferably chosen from glycerol, propylene glycol and sorbitol and polyalkylene glycol polymers.
  • the emollient oils are preferably present in amounts ranging from 1 % to 50% by weight and more preferentially from 5% to 40% by weight relative to the total weight of the composition.
  • one or more water-soluble anionic polymers comprising a Bronsted acid, in particular those derived from maleic acid and/or maleic anhydride that are described in patent application WO 02/49590.
  • one or more suspension agents preferably chosen from hydrophobic modified montmorillonite clays such as hydrophobic modified bentonites or hectorites.
  • CTFA name Stearalkonium Bentonite
  • CTFA name product of reaction of bentonite and the quaternary ammonium stearalkonium chloride
  • Tixogel MP 250 by the company Sud Chemie Rheologicals, United Catalysts Inc.
  • CTFA name Disteardimonium Hectorite
  • Bentone 38 or Bentone Gel by the company Elementis Specialities.
  • the suspension agents are preferably present in amounts ranging from 0.1 % to 5% by weight and more preferentially from 0.2% to 2% by weight relative to the total weight of the composition.
  • the compositions according to the invention may also additionally comprise at least one organic powder.
  • organic powders means any solid that is insoluble in the medium at room temperature (25°C).
  • organic powders that may be used in the composition of the invention, examples that may be mentioned include polyamide particles and especially those sold under the name Orgasol by the company Atochem; polyethylene powders; microspheres based on acrylic copolymers, such as those made of ethylene glycol dimethacrylate/lauryl methacrylate copolymer sold by the company Dow Corning under the name Polytrap; polymethyl methacrylate microspheres, sold under the name Microsphere M-100 by the company Matsumoto or under the name Covabead LH85 by the company Wackherr; ethylene-acrylate copolymer powders, such as those sold under the name Flobeads by the company Sumitomo Seika Chemicals; expanded powders such as hollow microspheres and especially microspheres formed from a terpolymer of vinylidene chloride, acrylonitrile and methacrylate and sold under the name Expancel by the company Kemanord Plast under the references 551 DE 12 (particle size of about 12 pm
  • the cosmetic compositions according to the invention may also comprise cosmetic adjuvants chosen from waxes, softeners, antioxidants, opacifiers, stabilizers, moisturizers, vitamins, fragrances, bactericides, preserving agents, polymers, fragrances, thickeners, propellants or any other ingredient usually used in cosmetics for this type of application.
  • cosmetic adjuvants chosen from waxes, softeners, antioxidants, opacifiers, stabilizers, moisturizers, vitamins, fragrances, bactericides, preserving agents, polymers, fragrances, thickeners, propellants or any other ingredient usually used in cosmetics for this type of application.
  • the waxes may be chosen from animal, fossil, plant, mineral or synthetic waxes. Mention may be made especially of beeswax, carnauba wax, candelilla wax, sugar cane wax, Japan wax, ozokerites, montan wax, microcrystalline waxes, paraffins, and silicone waxes and resins.
  • the thickeners which are preferably nonionic, may be chosen from modified or unmodified guar gums and celluloses such as hydroxypropyl guar gum, cetylhydroxyethylcellulose, silicas, for instance Bentone Gel MIO sold by the company NL Industries or Veegum Ultra sold by the company Polyplastic.
  • the thickeners may also be cationic, for instance Polyquaternium-37 sold under the name Salcare SC95 (Polyquaternium-37 (and) Mineral Oil (and) PPG-1 Trideceth-6) or Salcare SC96 (Polyquaternium-37 (and) Propylene Glycol Dicaprylate/Dicaprate (and) PPG-1 Trideceth-6) or other crosslinked cationic polymers, for instance those of the CTFA name Ethyl Acrylate/Dimethylaminoethyl Methacrylate Cationic Copolymer In Emulsion.
  • Salcare SC95 Polyquaternium-37 (and) Mineral Oil (and) PPG-1 Trideceth-6)
  • Salcare SC96 Polyquaternium-37 (and) Propylene Glycol Dicaprylate/Dicaprate (and) PPG-1 Trideceth-6)
  • other crosslinked cationic polymers for instance those of the CTFA name Ethyl Acrylate/Dimethylaminoethyl
  • compositions according to the invention may also contain one or more structuring or gelling agents for the said water-immiscible organic liquid phase, such as linear solid fatty alcohols and/or waxes; fatty acids or salts thereof (stearic acid, sodium stearate, 12-hydroxystearic acid); dibenzylidene alditols (DBS); lanosterol, N-acylamino acid derivatives; dicarboxylic or tricarboxylic acid derivatives such as alkyl-N,N'- dialkylsuccinamides (i.e.: dodecyl-N,N'-dibutylsuccinamide); elastomeric organopolysiloxanes such as those described in patent application WO 97/44010.
  • structuring or gelling agents for the said water-immiscible organic liquid phase such as linear solid fatty alcohols and/or waxes; fatty acids or salts thereof (stearic acid, sodium stearate, 12-hydroxystearic
  • Composition (A) according to the invention may also be pressurized and may be conditioned in an aerosol device formed by:
  • propellants generally used in products of this type and that are well known to those skilled in the art are, for instance, dimethyl ether (DME); volatile hydrocarbons such as n-butane, propane, isobutane and mixtures thereof, optionally with at least one chlorohydrocarbon and/or fluorohydrocarbon; among these derivatives, mention may be made of the compounds sold by the company DuPont de Nemours under the names Freon® and Dymel®, and in particular monofluorotrichloromethane, difluorodichloromethane, tetrafluorodichloroethane and 1 , 1 -difluoroethane sold especially under the trade name Dymel 152 A by the company DuPont. Carbon dioxide, nitrous oxide, nitrogen or compressed air may also be used as propellant.
  • DME dimethyl ether
  • volatile hydrocarbons such as n-butane, propane, isobutane and mixtures thereof, optionally with at least one chlorohydrocarbon and/or flu
  • the dispensing means which forms a part of the aerosol device, is generally formed by a dispensing valve controlled by a dispensing head, which itself comprises a nozzle via which the aerosol composition is vaporized.
  • the container containing the pressurized composition may be opaque or transparent. It may be made of glass, a polymer or a metal, optionally coated with a protective varnish coat.
  • Composition in powder form Composition (A) according to the invention may be in powder form, and, in this case, comprises a particulate phase comprising at least one filler.
  • filler should be understood as meaning colourless or white, mineral or synthetic particles of any shape, which are insoluble in the medium of the composition, irrespective of the temperature at which the composition is manufactured.
  • the filler(s) are present in concentrations preferably ranging from 50% to 99% by weight, more preferentially from 75% to 99% by weight and even more preferentially from 80% to 99% by weight relative to the total weight of the composition.
  • the composition according to the invention comprises a mixture of spherical particles and of lamellar particles.
  • the term "spherical particles” means particles in the form or substantially in the form of a sphere, which are insoluble in the medium of the composition according to the invention, even at the melting point of the medium (about 100°C).
  • lamellar particles means herein particles of parallelepipedal shape (rectangular or square surface), discoid shape (circular surface) or ellipsoid shape (oval surface), characterized by three dimensions: a length, a width and a height, these particles being insoluble in the medium of the composition according to the invention, even at the melting point of the medium (about 100°C).
  • the spherical particles used according to the invention have or substantially have the shape of a sphere and may be hollow or solid.
  • the particles of the invention have a particle size (number-average diameter) ranging from 0.1 pm to 250 pm, better still ranging from 1 pm to 150 pm and better still from 10 pm to 100 pm.
  • the spherical particles may be organic or mineral microspheres.
  • spherical particles that may be used in the composition of the invention, examples that may be mentioned include silica powder; polyamide particles and especially Nylon 12, for instance the product sold under the name Orgasol by the company Atochem; polyethylene powders; microspheres based on acrylic copolymers, such as those made of ethylene glycol dimethacrylate/lauryl methacrylate copolymer sold by the company Dow Corning under the name Polytrap; expanded powders such as hollow microspheres, and especially the microspheres sold under the name Expancel by the company Kemanord Plast or under the name Micropearl F 80 ED by the company Matsumoto; powders of natural organic materials such as corn starch, wheat starch or rice starch, that may or may not be crosslinked, starch powders crosslinked with octenylsuccinate anhydride, sold under the name Dry- Flo by the company National Starch; silicone resin microbeads, in particular silsesquioxane powders described especially in patent EP 293
  • a natural starch from corn, wheat or rice will be chosen, and more particularly a corn starch (INCI name: Zea mays starch).
  • These spherical particles may be present in amounts preferably ranging from 20% to 100% by weight, more preferentially from 20% to 50% and more particularly from 25% to 35% by weight relative to the total weight of the mixture of spherical particles and lamellar particles.
  • lamellar particles are particles of parallelepipedal shape (rectangular or square surface), discoid shape (circular surface) or ellipsoid shape (oval surface), characterized by three dimensions: a length, a width and a height.
  • the shape is circular, the length and the width are identical and correspond to the diameter of a disc, whereas the height corresponds to the thickness of the disc.
  • the surface is oval, the length and the width correspond, respectively, to the large axis and the small axis of an ellipse and the height corresponds to the thickness of the elliptic disc formed by the platelet.
  • the length and the width may be of identical or different dimensions: when they are of the same dimension, the shape of the surface of the parallelepiped is a square; in the contrary case, the shape is rectangular.
  • the height it corresponds to the thickness of the parallelepiped.
  • the length of the lamellar particles used according to the invention preferably ranges from 0.01 to 100 pm, better still from 0.1 to 50 pm and even better still from 1 to 50 pm.
  • the width of these platelets preferably ranges from 0.01 to 100 pm, better still from 0.1 to 50 pm and even better still from 1 to 10 pm.
  • the height (thickness) of these platelets preferably ranges from 0.1 nm to 1 m (0.1 to 1000 nm), better still from 1 nm to 600 nm and even better still from 1 nm to 500 nm.
  • lamellar particles that may be used in the composition of the invention, mention may be made of lamellar silicates.
  • Lamellar silicates that may be mentioned include clays, talcs, micas, nacres and perlites, and mixtures thereof.
  • Clays are mixed silicates of natural or synthetic origin containing several (two or more) types of cations chosen from alkali metals (for example Na, Li, K) or alkaline-earth metals (for example Be, Mg, Ca), transition metals and aluminium.
  • alkali metals for example Na, Li, K
  • alkaline-earth metals for example Be, Mg, Ca
  • clays that may be used in the invention examples include sodium magnesium silicate (CTFA name: Sodium magnesium silicate), clays of the kaolin family, such as kaolin or kaolinite, dickite and nacrite; clays of the halloysite, dombassite, antigorite, benthierine or pyrophyllite family; montmorillonites; beidellite; vermiculites; stevensite; hectorites; saponites; chlorites; sepiolite; smectite, and also these clays chemically modified, for example, with acrylic acids, polysaccharides (for example carboxymethylcellulose) or organic cations, and mixtures thereof.
  • CFA name Sodium magnesium silicate
  • clays of the kaolin family such as kaolin or kaolinite, dickite and nacrite
  • clays of the halloysite, dombassite, antigorite, benthierine or pyrophyllite family montmorillonites; beidellite; vermiculites;
  • Talcs are hydrated magnesium silicates usually comprising aluminium silicate.
  • the crystal structure of talc consists of repeated layers of a sandwich of brucite between layers of silica.
  • Micas are aluminium silicates optionally comprising iron and/or alkali metals. They have the property of being able to divide into thin layers (about 1 pm). They generally range in size from 5 to 150 pm, preferably from 10 to 100 pm and better still from 10 to 60 pm or the largest dimension (length), and a height (thickness) of from 0.1 to 0.5 pm.
  • Micas that may be mentioned include phlogopite, muscovite, fluorophlogopite and vermiculite, and mixtures thereof. Mention may also be made of micaceous clays such as illite.
  • nacres should be understood as meaning iridescent particles, produced especially by certain molluscs in their shell or else synthesized, which serve to modify the texture of the composition and also the matt/gloss effect. Nacres are generally micas that are surface-treated to obtain this iridescent effect. Among the nacres that may be used in the invention, mention may be made, for example, of micas coated with titanium oxide, with iron oxide, with natural pigment and/or with bismuth oxychloride, such as coloured or uncoloured titanium oxide- mica (or titanium-mica), and mixtures thereof.
  • the perlites that may be used according to the invention are generally aluminosilicates of volcanic origin and have as the composition:
  • the perlite is ground, dried and then calibrated in a first step.
  • the product obtained, known as perlite ore, is grey-coloured and has a size of about 100 pm.
  • the perlite ore is then expanded (1000°C/2 seconds) to give more or less white particles.
  • the temperature reaches 850-900°C, the water trapped in the structure of the material evaporates and brings about the expansion of the material relative to its original volume.
  • the expanded perlite particles in accordance with the invention may be obtained via the expansion process described in patent US 5 002 698.
  • the perlite particles used are ground: in this case, they are known as Expanded Milled Perlite (EMP). They preferably have a particle size defined by a median diameter D 50 ranging from 0.5 to 50 pm and preferably from 0.5 to 40 pm. Preferably, the perlite particles used have an untamped apparent density at 25°C ranging from 10 to 400 kg/m 3 (standard DIN 53468) and preferably from 10 to 300 kg/m 3 .
  • EMP Expanded Milled Perlite
  • the expanded perlite particles according to the invention have a water- absorbing capacity, measured at the wet point, ranging from 200% to 1500% and preferably from 250% to 800%.
  • the wet point corresponds to the amount of water that needs to be added to 1 g of particle in order to obtain a homogeneous paste.
  • This method is derived directly from that of the oil uptake applied to solvents.
  • the measurements are taken in the same manner by means of the wet point and the flow point, which have, respectively, the following definition: wet point: mass expressed in grams per 100 g of product corresponding to the production of a homogeneous paste during the addition of a solvent to a powder; flow point: mass expressed in grams per 100 g of product at and above which the amount of solvent is greater than the capacity of the powder to retain it. This is reflected by the production of a more or less homogeneous mixture that flows on a glass plate.
  • the wet point and the flow point are measured according to the following protocol:
  • the lamellar particles will be chosen from an expanded perlite, sodium magnesium silicate; kaolin; kaolinite; a montmorillonite; a hectorite; a talc; a mica; a nacre, and mixtures thereof.
  • the lamellar particles will be chosen from expanded perlite, kaolin and a talc, or mixtures thereof.
  • composition of the invention as lamellar particles, of kaolin such as the product sold under the name Coslin C- 100 by the company Engelhard; talc such as the products sold under the names Rose Talc and Talc SG-2000 by the company Nippon Talc; mica such as the products sold under the names Mica M RP and Silk Mica by the company Merck; titanium micas such as mica-titanium oxide-brown iron oxide (CTFA name: Mica/Iron oxides/Titanium dioxide) sold under the name Cloisonne Rouge Flambe 440 X by the company Engelhard; a modified hectorite, for instance a Bentone; expanded perlite, INCI name: Expanded Milled Perlite, such as the product sold under the name Optimat 1430 OR by the company World Minerals.
  • lamellar particles may be present in amounts preferably ranging from 40% to 100% by weight, more preferentially from 50% to 91 % and better still from 60% to 80% by weight relative to the total weight of the mixture of spherical particles and lamellar particles.
  • the particulate phase of the composition according to the invention may comprise pigments.
  • pigments should be understood as meaning mineral or organic particles that are insoluble in the liquid organic phase, and which are intended to colour and/or opacify the composition.
  • the pigments may be mineral or organic pigments.
  • Pigments that may be used include metal oxides, for instance iron oxides (especially yellow, red, brown or black iron oxides), titanium dioxides, cerium oxide, zirconium oxide, chromium oxide; manganese violet, ultramarine blue, Prussian blue and ferric blue, and mixtures thereof.
  • Iron oxide or titanium dioxide pigments are preferably used.
  • the pigments may be treated with a hydrophobic agent to make them compatible with the organic phase of the composition.
  • the hydrophobic treatment agent may be chosen from silicones such as methicones, dimethicones and perfluoroalkylsilanes; fatty acids such as stearic acid; metal soaps such as aluminium dimyristate, the aluminium salt of hydrogenated tallow glutamate, perfluoroalkyl phosphates, perfluoroalkylsilanes, perfluoroalkylsilazanes, polyhexafluoropropylene oxides, polyorganosiloxanes comprising perfluoroalkyl perfluoropolyether groups, amino acids, N-acylamino acids or salts thereof; lecithin, isopropyl triisostearyl titanate, and mixtures thereof.
  • the N-acylamino acids may comprise an acyl group containing from 8 to 22 carbon atoms, for instance a 2-ethylhexanoyl, caproyl, lauroyl, myristoyl, palmitoyi, stearoyl or cocoyl group.
  • the salts of these compounds may be the aluminium, magnesium, calcium, zirconium, zinc, sodium or potassium salts.
  • the amino acid may be, for example, lysine, glutamic acid or alanine.
  • alkyl mentioned in the compounds cited above especially denotes an alkyl group containing from 1 to 30 carbon atoms and preferably containing from 5 to 16 carbon atoms.
  • Hydrophobic-treated pigments are described especially in patent application EP- A-1 086 683.
  • the particulate phase of the invention may comprise dyes.
  • composition according to the invention may also comprise water-soluble or liposoluble dyes.
  • liposoluble dyes should be understood as meaning compounds that are generally organic, which are soluble in fatty substances such as oils.
  • the liposoluble dyes are, for example, Sudan red, D&C Red 17, D&C Green 6, ⁇ - carotene, soybean oil, Sudan Brown, D&C Yellow 1 1 , D&C Violet 2, D&C Orange 5, quinoline yellow, annatto and bromo acids. Fragrances
  • composition (A) also contains at least one fragrancing substance.
  • fragmenting substance means any perfume or aroma capable of giving off a pleasant odour.
  • the amount of fragrancing substance(s) will be from 1 % to 30% by weight and better still from 2% to 25% by weight relative to the total weight of the composition.
  • the perfumes as used in the composition (A) are compositions especially containing the raw materials described in S. Arctander, Perfume and Flavor Chemicals (Edition 2003) and in Flavor and Fragrance Materials - 1991 , Allured Publishing Co. Wheaton, III.
  • They may be natural products (essential oils, absolutes, resinoids, resins or concretes) and/or synthetic products (terpene or sesquiterpene hydrocarbons, alcohols, phenols, aldehydes, ketones, ethers, acids, esters, nitriles and peroxides, which are saturated or unsaturated, and aliphatic or cyclic).
  • an essential oil is an odoriferous product generally of complex composition, obtained from a botanically defined plant raw material, either by steam entrainment, or by dry distillation, or via an appropriate mechanical process without heating (cold pressing).
  • the essential oil is usually separated from the aqueous phase via a physical process that does not result in any significant change in the composition.
  • the choice of technique depends mainly on the starting material: its original state and its characteristics, its actual nature.
  • the "essential oil/plant starting material” yield may be extremely variable depending on the plant: 15 ppm to more than 20%. This choice conditions the characteristics of the essential oil, in particular viscosity, colour, solubility, volatility, richness or poorness in certain constituents. Steam entrainment
  • Steam entrainment corresponds to vaporization in the presence of steam of a sparingly water-miscible substance.
  • the starting material is placed in contact with boiling water or steam in an alambic.
  • the steam entrains the essential oil vapour, which is condensed in the condenser and recovered as a liquid phase in a Florentine vase (or essence jar) where the essential oil is separated from the water by settling.
  • the aqueous distillate that remains after the steam entrainment, once the separation of the essential oil has been performed, is known as the "aromatic water” or "hydrolate” or "distilled floral water”. Dry distillation
  • the essential oil is obtained by distillation of woods, barks or roots, without addition of water or steam, in a closed chamber designed so that the liquid is recovered at the bottom.
  • Cade oil is the best known example of a product obtained in this way.
  • Essential oils are generally volatile and liquid at room temperature, which distinguishes them from “set” oils. They are more or less coloured and their density is generally less than that of water. They have a high refractive index and most of them deflect polarized light. They are liposoluble and soluble in the usual organic solvents, entrainable with steam, and very sparingly soluble in water.
  • Apiaceae for example Umbelliferae: dill, angelica, coriander, sea fennel, carrot, parsley
  • Asteraceae yarrow, artemisia, camomile, helichrysum
  • Geraniaceae geranium
  • Lamiaceae thyme, oregano, monarda, savory, basil, marjorams, mints, patchouli, lavenders, sages, catnip, rosemary, hyssop, balm
  • Magnoliaceae magnolia
  • Myrtaceae eucalyptus, tea tree, paperbark tree, cajuput, backhousia, clove, myrtle
  • Thymelaceae agar wood
  • Verbenaceae lantana, verbena
  • Zingiberaceae galangal, turmeric, cardamom, ginger
  • Zygophyllaceae Mention may be made especially of the essential oils extracted from flowers (lily, lavender, rose, jasmine, ylang ylang, neroli), from stems and leaves (patchouli, geranium, petitgrain), from fruit (coriander, aniseed, cumin, juniper), from fruit peel (bergamot, lemon, orange), from roots (angelica, celery, cardamom, iris, rattan palm, ginger), from wood (pinewood, sandalwood, gaiac wood, rose of cedar, camphor), from grasses and gramineae (tarragon, rosemary, basil, lemongrass, sage, thyme), from needles and branches (spruce, fir, pine, dwarf pine) and from resins and balms (galbanum, elemi, benjoin, myrrh, olibanum, opopanax).
  • fragrancing substances are especially: geraniol, geranyl acetate, farnesol, borneol, bornyl acetate, linolool, linalyl acetate, linalyl propionate, linalyl butyrate, tetrahydrolinolool, citronellol, citronellyl acetate, citronellyl formate, citronellyl propionate, dihydromyrcenol, dihydromyrcenyl acetate, tetrahydromyrcenol, terpineol, terpinyl acetate, nopol, nopyl acetate, nerol, neryl acetate, 2-phenylethanol, 2-phenylethyl acetate, benzyl alcohol, benzyl acetate, benzyl salicylate, styrallyl acetate, benzyl benzoate, amyl sal
  • vetiverol a-hexylcinnamaldehyde, 2-methyl-3-(p-tert-butylphenyl)propanal, 2- methyl-3-(p-isopropyl-phenyl)-propanal, 3-(p-tert-butylphenyl)propanal, 2,4- dimethylcyclohex-3-enylcarboxaldehyde, tricyclodecenyl acetate, tricyclodecenyl propionate, 4-(4-hydroxy-4-methylpentyl)-3-cyclohexenecarboxaldehyde, 4-(4- methyl-3-pentenyl)-3-cyclohexenecarboxaldehyde, 4-acetoxy-3- pentyltetrahydropyran, 3-carboxymethyl-2-pentylcyclopentane, 2-n-4- heptylcyclopentanone, 3-methyl-2-pentyl-2-cyclopentenone, menthone
  • the fragrancing substances will preferably be chosen such that they produce notes (head, heart and base) in the following olfactory families:
  • composition (A) that produces a fragrance having at least one note in common with those of the fragrance produced by the oral composition (B) will be used. More preferentially, a composition (A) that produces a fragrance having at least one head note and/or heart note in common with those of the fragrance produced by the oral composition (B) will be used.
  • composition (B) of the invention may be chosen from:
  • the edible fragrancing substances are chosen such that composition (B) produces a fragrance having at least one note in common with at least one of those of the fragrance produced by composition (A).
  • composition (A) that produces a perfume with at least one head note and/or heart note and the edible fragrancing substance(s) will be chosen such that composition (B) produces a perfume having at least the same head note and/or the same heart note as the perfume produced by composition (A).
  • the daily dose of the edible fragrancing molecules of the invention will preferably range from 10 "5 to 200 mg depending on the nature of the substance and the galenical form containing it, and more preferentially from 0.05 to 85 mg. This dose may be taken in a single intake or in several intakes in the course of the day.
  • the compositions (B) of the invention containing the various edible fragrancing substances, independently of each other, may be in liquid or solid form. They may be applied directly via the oral or sublingual route (placed under the tongue until fully dissolved, by absorption through the mucous membranes of the tongue and the mouth).
  • They may be in the form of capsules especially for melting under the tongue, or in the form of tablets; gel capsules; granules; bars; pastes; pastilles for sucking; hard, soft or gelled sweets, dragees; gums for masticating such as chewing gums; drinks; solutions to be incorporated into pastries (for example macaroons), confectioneries, flavoured sugars; powders for diluting in water at the time of use; products that may be applied sublingually.
  • the various presentation or administration forms may be prepared according to the usual methods, with standard excipients that are compatible with oral administration.
  • compositions (B) of the invention may also comprise one or more additives that are suitable for oral application, chosen, for example, from food colorants, preserving agents, antioxidants, texturing agents such as thickeners or gelling agents, flavour enhancers, sweeteners, emulsifiers, acidifiers and stabilizers.
  • additives that are suitable for oral application, chosen, for example, from food colorants, preserving agents, antioxidants, texturing agents such as thickeners or gelling agents, flavour enhancers, sweeteners, emulsifiers, acidifiers and stabilizers.
  • the invention also relates to a deodorizing kit or device comprising at least two conditionings, characterized in that it comprises at least:
  • composition (B) as defined previously.
  • the deodorizing composition (A) applied topically may be conditioned in a bottle, a pressurization device such as a pump-action bottle or an aerosol can, a device suited for a perfumed talc equipped, for example, with a suitable grille or applicator, a tube in the case of perfumed milks or creams, or wipes.
  • a pressurization device such as a pump-action bottle or an aerosol can
  • a device suited for a perfumed talc equipped, for example, with a suitable grille or applicator a tube in the case of perfumed milks or creams, or wipes.
  • the fragrancing composition (B) applied orally may be conditioned in a case or a pillbox, a flask or bottle (in the case of drinks or mouthwashes), conditioning suitable for gel capsules, chewing gums or tablets, blister packs or sachets, or in drinkable vials.
  • composition (B) applied orally may be an oral perfuming agent containing at least two components, characterized in that it comprises:
  • At least one component (B-i) comprising, in a support suitable for oral application, at least one edible fragrancing substance (1 ) that is capable, after ingestion or placing in the mouth, of producing, from within the body out to the human keratin materials, a perfume whose diffusion reaches its maximum in a time of less than 4 hours 30 minutes, and
  • compositions (B 2 ) comprising, in a support suitable for oral application, at least one edible fragrancing substance (2) that is capable, after ingestion or placing in the mouth, of producing, from within the body out to the human keratin materials, a perfume whose diffusion reaches its maximum in a time of greater than or equal to 4 hours 30 minutes; the order of ingestion of compositions (B-i) and (B 2 ) being irrelevant; compositions (B-i) and (B 2 ) possibly being conditioned separately or together in the same galenical form.
  • the edible fragrancing substances (1 ) and (2) in accordance with the invention are chosen from those that produce perfumes which have notes (head, heart and base notes) in the following olfactory families:
  • edible fragrancing substances (1 ) that are capable, after ingestion, of producing, from within the body out to the human keratin materials, a perfume whose diffusion reaches its maximum in a time of less than 4 hours 30 minutes, mention may be made preferentially of:
  • edible fragrancing substances (2) that are capable, after ingestion, of producing, from within the body out to the human keratin materials, a perfume whose diffusion reaches its maximum in a time of greater than 4 hours 30 minutes
  • examples that may be mentioned include:
  • Example 1 Antiperspirant roll-on combined with 10 oral perfume capsules a) Oral perfume:
  • the fatty alcohols are left to melt on a water bath at 80°C for 20 minutes.
  • the aqueous phase, the aluminium hydroxychloride and the hydrophilic preserving agents are incorporated with stirring at 3500 rpm at 65°C and are stirred for 10 minutes.
  • the mixture is allowed to cool to room temperature with gentle stirring. A fluid, homogeneous white emulsion is obtained.
  • the antiperspirant roll-on is applied to the armpits, and three capsules of ethyl maltol and three capsules of essence of rose are then ingested and left to melt under the tongue for as long as possible.
  • the intrinsic odour obtained with the antiperspirant roll-on is reinforced by a very pleasant odour diffusing from the entire body judged in the majority as "floral pink flowers and floral white flowers", which persists for at least 6 hours after ingestion.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne un procédé cosmétique permettant de traiter les odeurs corporelles et comprenant les étapes suivantes : (1) application directe sur les zones de peau à traiter d'une composition désodorisante (A) contenant au moins un principe actif désodorisant dans un support cosmétiquement acceptable; (2) ingestion d'au moins une composition (B) contenant, dans un excipient adapté à l'administration par voie orale, au moins un parfum comestible capable d'entraîner, depuis l'intérieur de l'organisme, le dégagement d'une odeur au niveau des structures à base de kératine du corps humain. L'ordre des étapes n'a aucune importance et l'utilisation des compositions (A) et (B) peut se faire de façon simultanée ou séquentielle dans un intervalle de temps allant de 30 secondes à 12 heures. L'invention concerne également un nécessaire ou un dispositif désodorisant comprenant au moins deux compartiments et caractérisé en ce qu'il comprend un premier conditionnement contenant la composition (A) telle que définie précédemment et un second conditionnement contenant la composition (B) telle que définie précédemment.
PCT/EP2011/070062 2010-12-02 2011-11-14 Procédé de traitement des odeurs corporelles combinant un produit désodorisant topique et un parfum administré par voie orale; nécessaire désodorisant Ceased WO2012072409A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1060011 2010-12-02
FR1060011A FR2968212B1 (fr) 2010-12-02 2010-12-02 Procede de traitement des odeurs corporelles associant un produit deodorant topique a un parfum oral ; kit de desodorisation
US41933110P 2010-12-03 2010-12-03
US61/419,331 2010-12-03

Publications (2)

Publication Number Publication Date
WO2012072409A2 true WO2012072409A2 (fr) 2012-06-07
WO2012072409A3 WO2012072409A3 (fr) 2012-09-27

Family

ID=44314174

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/070062 Ceased WO2012072409A2 (fr) 2010-12-02 2011-11-14 Procédé de traitement des odeurs corporelles combinant un produit désodorisant topique et un parfum administré par voie orale; nécessaire désodorisant

Country Status (2)

Country Link
FR (1) FR2968212B1 (fr)
WO (1) WO2012072409A2 (fr)

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
EP0293795A1 (fr) 1987-05-29 1988-12-07 Toshiba Silicone Company, Ltd. Composition de maquillage ou composition cosmétique
US4822596A (en) 1973-11-08 1989-04-18 Lever Brothers Company Skin composition
US4904463A (en) 1988-03-22 1990-02-27 The Procter & Gamble Company Aerosol antiperspirant compositions
US5002698A (en) 1986-01-10 1991-03-26 Ciba-Geigy Corporation Sulfur- and nitrogen-containing lubricant additives
WO1997044010A1 (fr) 1996-05-24 1997-11-27 Colgate-Palmolive Company Composition de creme cosmetique contenant une matiere au silicone en gel
JPH10245343A (ja) 1997-03-03 1998-09-14 Taisho Pharmaceut Co Ltd 体臭改善用経口組成物
CN1217889A (zh) 1997-11-25 1999-06-02 刘安丽 体香糖
EP1086683A1 (fr) 1999-09-22 2001-03-28 L'oreal Composition de gel et son utilisation en cosmétique
WO2002049590A2 (fr) 2000-12-21 2002-06-27 Unilever Plc Produits antisudorifiques
JP2002224203A (ja) 2001-02-02 2002-08-13 Rikomu:Kk 植物抽出物を有効成分とする消臭剤
WO2003045166A1 (fr) 2001-11-26 2003-06-05 V. Mane Fils Capsule a solubilisation et liberation du contenu rapides
WO2004010574A1 (fr) 2002-07-10 2004-01-29 Thomson Licensing S.A. Adaptateur vhf pour reseau cable
US20050063928A1 (en) 2003-09-18 2005-03-24 Withiam Michael C. Compositions comprising odor neutralizing metal oxide silicates
US20050084464A1 (en) 2003-10-16 2005-04-21 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
US20050084474A1 (en) 2003-10-16 2005-04-21 Kimberly-Clark Corporation Method for reducing odor using coordinated polydentate compounds
US6916465B2 (en) 2000-03-23 2005-07-12 Cognis Deutschland Gmbh & Co. Kg Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives
EP1658863A1 (fr) 2003-08-08 2006-05-24 Kao Corporation Deodorant
WO2006129876A1 (fr) 2005-05-31 2006-12-07 Kanebo Foods, Ltd. Agent d’amelioration des odeurs corporelles destine a etre absorbe par le corps, boisson / aliment l’utilisant et procede d’amelioration des odeurs corporelles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512555A (en) * 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US7128933B2 (en) * 2000-09-01 2006-10-31 Mitchell Kurk Composition and method for the treatment of personal odors

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
US4822596A (en) 1973-11-08 1989-04-18 Lever Brothers Company Skin composition
US5002698A (en) 1986-01-10 1991-03-26 Ciba-Geigy Corporation Sulfur- and nitrogen-containing lubricant additives
EP0293795A1 (fr) 1987-05-29 1988-12-07 Toshiba Silicone Company, Ltd. Composition de maquillage ou composition cosmétique
US4904463A (en) 1988-03-22 1990-02-27 The Procter & Gamble Company Aerosol antiperspirant compositions
WO1997044010A1 (fr) 1996-05-24 1997-11-27 Colgate-Palmolive Company Composition de creme cosmetique contenant une matiere au silicone en gel
JPH10245343A (ja) 1997-03-03 1998-09-14 Taisho Pharmaceut Co Ltd 体臭改善用経口組成物
CN1217889A (zh) 1997-11-25 1999-06-02 刘安丽 体香糖
EP1086683A1 (fr) 1999-09-22 2001-03-28 L'oreal Composition de gel et son utilisation en cosmétique
US6916465B2 (en) 2000-03-23 2005-07-12 Cognis Deutschland Gmbh & Co. Kg Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives
WO2002049590A2 (fr) 2000-12-21 2002-06-27 Unilever Plc Produits antisudorifiques
JP2002224203A (ja) 2001-02-02 2002-08-13 Rikomu:Kk 植物抽出物を有効成分とする消臭剤
WO2003045166A1 (fr) 2001-11-26 2003-06-05 V. Mane Fils Capsule a solubilisation et liberation du contenu rapides
WO2004010574A1 (fr) 2002-07-10 2004-01-29 Thomson Licensing S.A. Adaptateur vhf pour reseau cable
EP1658863A1 (fr) 2003-08-08 2006-05-24 Kao Corporation Deodorant
US20050063928A1 (en) 2003-09-18 2005-03-24 Withiam Michael C. Compositions comprising odor neutralizing metal oxide silicates
US20050084464A1 (en) 2003-10-16 2005-04-21 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
US20050084474A1 (en) 2003-10-16 2005-04-21 Kimberly-Clark Corporation Method for reducing odor using coordinated polydentate compounds
WO2006129876A1 (fr) 2005-05-31 2006-12-07 Kanebo Foods, Ltd. Agent d’amelioration des odeurs corporelles destine a etre absorbe par le corps, boisson / aliment l’utilisant et procede d’amelioration des odeurs corporelles

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Flavor and Fragrance Materials", 1991, ALLURED PUBLISHING CO
"Substances ar6matisantes et sources naturelles de mati6res ar6matisantes, 4th edition,", vol. 1, 1992, MAISONNEUVE
C. FOX, COSMETICS AND TOILETRIES, vol. 101, November 1986 (1986-11-01), pages 101 - 112
S. ARCTANDER: "Perfume and Flavor Chemicals", 2003

Also Published As

Publication number Publication date
WO2012072409A3 (fr) 2012-09-27
FR2968212B1 (fr) 2013-06-14
FR2968212A1 (fr) 2012-06-08

Similar Documents

Publication Publication Date Title
JP5872134B2 (ja) 干渉微粒子に基づく脱臭及び／または制汗組成物；メイクアップ方法並びに発汗及び／または身体の臭気、特に腋窩の臭気の処置のための方法
ES2428906T3 (es) Procedimiento cosmético de perfumado; composición perfumante, procedimiento de tratamiento de olores corporales
JP6001051B2 (ja) ４−（３−エトキシ−４−ヒドロキシフェニル）アルキルケトン化合物または２−エトキシ−４−ヒドロキシアルキルフェノール化合物を使用するヒトの体臭を処置する美容方法
US10076472B2 (en) Aqueous composition comprising hydrophobic silica aerogel particles, a deodorant agent and/or an antiperspirant active agent and a specific alcohol
FR2956582A1 (fr) Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16
ES2717655T3 (es) Composición perfumante acuosa que comprende al menos un alcano lineal volátil; procedimiento de perfumado
CN107864620A (zh) 麝香组合物和其使用方法
WO2012059343A1 (fr) Composition sous forme de poudre comprenant au moins une huile essentielle et une fécule de manioc modifiée
WO2013076675A1 (fr) Composition de fragrance de type émulsion stabilisée par des particules
WO2013076673A1 (fr) Composition de type émulsion stabilisée par des particules basée sur des particules de silice hydrophobes
WO2012072409A2 (fr) Procédé de traitement des odeurs corporelles combinant un produit désodorisant topique et un parfum administré par voie orale; nécessaire désodorisant
EP2782546B1 (fr) Composition deodorante liquide de type emulsion pickering
KR102157027B1 (ko) 탈취 활성제로서 단일불포화 지방산 또는 이의 염들 및/또는 이의 에스테르들 또는 아미드들 중 하나의 미용 용도
JP2005187469A (ja) 亜鉛ピドラートと制汗アルミニウム塩の組合せを含有する脱臭化粧品用組成物
RU2789388C2 (ru) Водная композиция, содержащая частицы аэрогеля гидрофобного диоксида кремния, дезодорант и/или активный антиперспирант и специфический спирт
WO2011067104A1 (fr) Procédé d'aromatisation combinant un parfum topique avec une composition destinée à parfumer la cavité orale et/ou les lèvres, et nécessaire d'aromatisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11781572

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11781572

Country of ref document: EP

Kind code of ref document: A2